FdaApplication
ANDA 208452
Identifiers
- fda_app_no: ANDA208452
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2025-05-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE | 200MG;EQ 25MG BASE;300MG | TABLET;ORAL |
1 product